VIPER: A Leading Digital Pathology Cloud Platform Available Free to All Pathologists

What Makes VIPER Different?

Time Tested World Class Pathology Workflows

For over ten years VIPER has allowed pathology groups to  go digital and collaborate on groundbreaking cancer research across dozens of cancer types.  In addition, we are enhancing the system to include Artificial Intelligence, telepathology, collaboration, cloud storage and built in APIs for integration by partners and biopharmas.

Our workflow engine allows you to manage your entire digital pathology process in one interface, and our integrated electronic pathology forms have been custom created to support almost 50 specific tumor types.

VIPER has been used in many different applications including:

- Rapid Central Pathology Review for Patient Enrollment

- Biospecimen Quality Control

- Quality Assurance

- Training and Education

 

Sign up for a Free Account 

Developing VIPER

Deep Lens’ VIPER platform was not built at just one hospital, although it was developed by the innovation group at one of the largest pediatric oncology facilities in the United States, Nationwide Children’s Hospital (NCH) in Columbus, Ohio. The platform was built by expert pathology groups working with the NCH team from around the world that focused on specific tumor types and subtypes. NCH played the role of global biospecimen repository and facilitated research projects globally. Those participants, at over 65 major institutions, helped forge the requirements that today make up the VIPER platform.

 

Forms For Different Tumor Types

We have almost 50 forms that have been designed to specific tumor types. Those include:

Available Cancer Types    
Acute Myeloid Leukemia [LAML] Kidney Chromophobe [KICH] Rectum adenocarcinoma [READ]
Adrenocortical carcinoma [ACC] Kidney renal clear cell carcinoma [KIRC] Sarcoma [SARC]
Bladder Urothelial Carcinoma [BLCA] Kidney renal papillary cell carcinoma [KIRP] Skin Cutaneous Melanoma [SKCM]
Brain Lower Grade Glioma [LGG] Liver hepatocellular carcinoma [LIHC] Stomach adenocarcinoma [STAD]
Breast invasive carcinoma [BRCA] Lung adenocarcinoma [LUAD] Testicular Germ Cell Tumors [TGCT]
Cervical squamous cell carcinoma and endocervical adenocarcinoma [CESC] Lung squamous cell carcinoma [LUSC] Thymoma [THYM]
Cholangiocarcinoma [CHOL] Lymphoid Neoplasm Diffuse Large B-cell Lymphoma [DLBC] Thyroid carcinoma [THCA]
Colon adenocarcinoma [COAD] Mesothelioma [MESO] Uterine Carcinosarcoma [UCS]
Esophageal carcinoma [ESCA] Ovarian serous cystadenocarcinoma [OV]  Uterine Corpus Endometrial Carcinoma [UCEC]
FFPE Pilot Phase II [FPPP]  Pancreatic adenocarcinoma [PAAD]  Uveal Melanoma [UVM]
Glioblastoma multiforme [GBM] Pheochromocytoma and Paraganglioma [PCPG]  
Head and Neck squamous cell carcinoma [HNSC]  Prostate adenocarcinoma [PRAD]  

 

No other system has that level of detail and expertise baked into the logic of their system.

 

Contact Us

 

AI-assisted Digital Pathology with Collaboration to speed time to treatment for patients